Abstract CT105: Safety and feasibility of chimeric antigen receptor modified T cells directed against mesothelin (CART-meso) in patients with mesothelin expressing cancers
A phase I study to evaluate the safety and feasibility of an intravenous infusion of autologous T cells transduced to express a chimeric antigen receptor directed against mesothelin (CART-meso) in patients with mesothelin expressing tumors is being conducted at the University of Pennsylvania. Here we report on the first five patients treated with CART-meso T cell infusion.Five patients with recurrent advanced stage cancers (two serous ovarian, two epithelial mesothelioma, and one pancreatic) who had received 4-12 prior regimens, were treated with a single infusion of CART-meso cells. Apheresed autologous T cells were transduced with a lentiviral vector expressing the CAR construct composed of an extracellular anti-mesothelin single chain variable fragment derived from mouse monoclonal antibody (SS1) fused to the intracellular signaling domains of 4-1BB (CD137) and TCRzeta. Each patient received a single dose of 1-3 × 10^7 CART-meso cells/m2. No lymphodepletion with chemotherapy was given prior to infusion.All subjects enrolled were successfully infused and there were no acute adverse events (AE) with infusion. To date, Grade 4 AEs have included sepsis(1), anemia(1), pleural effusions(1), tachypnea(1), dyspnea(1), and aspiration(1) and Grade 3 AEs have included sepsis(1), leukocytosis(2), DIC(1), tachycardia(1), dyspnea(1), hypotension(1), dusky extremities(1), fatigue(1), ascites(1), peritonitis(1), elevated LFTs(1), portal vein hypertension(1), and acute kidney injury(1). A...
Source: Cancer Research - Category: Cancer & Oncology Authors: Tanyi, J. L., Haas, A. R., Beatty, G. L., Morgan, M. A., Stashwick, C. J., O'Hara, M. H., Porter, D. L., Maus, M. V., Levine, B. L., Lacey, S. F., Nelson, A. M., McGarvey, M., Kerr, N. D., Plesa, G., June, C. H. Tags: Clinical Trials Source Type: research
More News: Anemia | Asbestosis | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Epithelial Cancer | Hypertension | Laboratory Medicine | Liver | Mesothelioma | Ovarian Cancer | Ovaries | Pancreas | Pancreatic Cancer | Pericarditis | Peritonitis | Study | Toxicology | University of Pennsylvania | Urology & Nephrology